This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

The government’s top vaccine official, working under Health Secretary Robert F. Kennedy Jr., restricted the approval of two ...

The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...

Pfizer exec Philip Dormitzer amid claims the COVID-19 vaccine announcement was delayed to avoid influencing the 2020 election ...

We view Pfizer’s dividends and share repurchase levels as reasonable. Pfizer has generally targeted close to a 50% payout in dividends as a percentage of normalized earnings, which seems about right ...

The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...

Another updated vaccine from Novavax is also expected to get the FDA's authorization this year. Packages of new COVID-19 vaccines from Pfizer and Moderna for fall 2024. Pfizer / Moderna ...

In November 2020, Pfizer released a statement sharing the results of its COVID-19 vaccine trials, stating that its vaccine was "95% effective against COVID-19 beginning 28 days after the first dose." ...

Pfizer's pediatric COVID-19 vaccine has an efficacy of 80.3%, according to a preliminary analysis, and meets "all immunobridging criteria required for Emergency Use Authorization," the company ...